Ameriprise Financial Inc Tg Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 132,343 shares of TGTX stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,343

Previous 130,418 1.48%

Holding current value

$3.15 Million

Previous $1.98 Million 18.71%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $25,641 - $36,940	1,925 Added 1.48%	132,343 $2.35 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $46,872 - $76,680	3,600 Added 2.84%	130,418 $1.98 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $425,916 - $1.2 Million	63,760 Added 101.11%	126,818 $2.17 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $72,773 - $230,682	-8,705 Reduced 12.13%	63,058 $527,000
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $1,548 - $3,500	-100 Reduced 0.14%	71,763 $1.78 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $735,158 - $1.39 Million	71,863 New	71,863 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $113,626 - $211,027	-5,217 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $169,552 - $255,424	5,217 New	5,217 $203,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $164,401 - $214,539	-3,951 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $99,841 - $216,909	3,951 New	3,951 $206,000
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $275,054 - $674,965	-30,905 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $113,147 - $253,393	15,847 Added 105.24%	30,905 $304,000
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $76,795 - $168,649	15,058 New	15,058 $167,000
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $832,624 - $1.61 Million	-95,704 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$7.35 - $12.3 $624,360 - $1.04 Million	-84,947 Reduced 47.02%	95,704 $785,000
Q3 2017 Nov 07, 2017	BUY	$10.0 - $12.7 $1.81 Million - $2.29 Million	180,651	180,651 $2.14 Million

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Tg Therapeutics, Inc. Transaction History